Published in Iyodenshi To Seitai Kogaku on April 01, 1980
A database for cell signaling networks. J Comput Biol (1998) 3.31
Plastic resin pellets as a transport medium for toxic chemicals in the marine environment. Environ Sci Technol (2001) 1.70
An ecological study on the association of public dental health activities and sociodemographic characteristics with caries prevalence in Japanese 3-year-old children. Caries Res (2006) 1.46
The detection of disease clustering in time. Biometrics (1984) 1.15
Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer (1995) 1.14
Lymphocyte subsets identified by monoclonal antibodies in healthy children. Pediatr Res (1986) 1.12
A pathway finding system for the cell signaling networks database. In Silico Biol (1999) 1.08
Antigenicity of reduced and alkylated Australia antigen. J Immunol (1974) 1.05
South-to-north gradient in distribution of the r determinant of hepatitis B surface antigen in Japan. J Infect Dis (1975) 1.01
Age, period and cohort analysis of trends in mortality from major diseases in Japan, 1955 to 1979: peculiarity of the cohort born in the early Showa Era. Stat Med (1987) 1.01
Adenosinetriphosphatase activity of erythrocyte membrane in hereditary spherocytosis. Life Sci (1967) 0.94
[Validity and reproducibility of a semi-quantitative food frequency questionnaire for nutritional education of patients of diabetes mellitus (FFQW65)]. Nihon Koshu Eisei Zasshi (2000) 0.90
Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction. Clin Exp Med (2001) 0.90
N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes. Environ Health Perspect (1994) 0.87
Mortality experience of cockpit crewmembers from Japan Airlines. Aviat Space Environ Med (1993) 0.87
[A statistical method for method-comparison studies--linear structural relationship considering measurement errors]. Rinsho Byori (1988) 0.87
Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol (2003) 0.87
Adjusting Moran's I for population density. Stat Med (1998) 0.86
Clinical features and course of type A and type B vitiligo. Br J Dermatol (1988) 0.85
[Studies on the operative factors affecting the reduction of chronic subdural hematoma, with special reference to the residual air in the hematoma cavity]. No Shinkei Geka (1989) 0.83
A gel filtration technique for separation of erythrocytes from human blood. J Lab Clin Med (1974) 0.82
Estimation of normal ranges of clinical laboratory data. Stat Med (1986) 0.81
Mantel-Haenszel-type tests for testing equivalence or more than equivalence in comparative clinical trials. Biometrics (1994) 0.80
Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience. Vox Sang (1993) 0.80
Development of a cell signaling networks database. Pac Symp Biocomput (1997) 0.79
Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas. Int J Hematol (1991) 0.79
A comparative study of alteration in lymphocyte subsets among varicella, hand-foot-and-mouth disease, scarlet fever, measles, and Kawasaki disease. Microbiol Immunol (1987) 0.78
[Age and sex dependent distribution pattern and normal range of blood cell parameters obtained by automated blood cell analyzer]. Rinsho Byori (1993) 0.78
Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys. Neurosurgery (1996) 0.78
Quantitative analysis of dystrophin gene amplification products using a PC-based image analysis system. Int J Biomed Comput (1993) 0.78
Re: Improved confidence intervals for the difference between binomial proportions based on paired data by Robert G. Newcombe, Statistics in Medicine, 17, 2635-2650 (1998) Stat Med (1999) 0.78
Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) (1996) 0.78
Physical and personality traits of preschool children in Fuzhou, China: only child vs sibling. Child Care Health Dev (2000) 0.77
Development of the receptor database (RDB): application to the endocrine disruptor problem. Bioinformatics (1999) 0.77
[Maximum likelihood estimation of date of infection in an outbreak of diarrhea due to contaminated foods assuming lognormal distribution for the incubation period]. Nihon Koshu Eisei Zasshi (1998) 0.77
Rates of endometriosis recurrence and pregnancy 1 year after treatment with intranasal buserelin acetate (Suprecur) (a prospective study). J Obstet Gynaecol Res (1999) 0.77
Spatial clusters of Creutzfeldt-Jakob disease mortality in Japan between 1995 and 2004. Neuroepidemiology (2008) 0.76
[Effect of calcitonin gene-related peptide and vasoactive intestinal polypeptide on delayed cerebral vasospasm studied after experimental subarachnoid hemorrhage in rabbits]. No Shinkei Geka (1994) 0.76
[A quantitative study of brain atrophy on computed tomography--multivariate analysis for comparison between the linear measurement method and the pixel count method]. No To Shinkei (1985) 0.75
A quantitative study of physiological cerebral atrophy with aging. A statistical analysis of the normal range. Neuroradiology (1987) 0.75
[The normal range of cerebral atrophy during aging: statistical analysis of 500 normal subjects]. No To Shinkei (1986) 0.75
Effect of calcitonin gene-related peptide on delayed cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Surg Neurol (1996) 0.75
[Up-dating the references for environmental health criteria for anionic surfactants and preparation of its first draft]. Eisei Shikenjo Hokoku (1991) 0.75
[Statistics on the crown prosthetic appliances in the clinical practice of students]. Nichidai Koko Kagaku (1987) 0.75
Cold activation of complement in sera from patients with persistent hepatitis C virus infection on interferon therapy. J Gastroenterol Hepatol (1996) 0.75
[A structure based pharmaceutical database for drug interactions]. Eisei Shikenjo Hokoku (1996) 0.75
[Population study of serum protein. Part II. Prevalence of M-protein and statistical studies on the blood chemical data (author's transl)]. Rinsho Byori (1977) 0.75
[Clinical epidemiology of bronchial asthma in children report. No. III. Comparison of prevalence of asthma with 1982 and 1990 and environmental factors]. Arerugi (1992) 0.75
[11 cases of adult acute leukemia surviving more than 5 years]. Rinsho Ketsueki (1986) 0.75
[Dissemination of the Japanese version of the International Chemical Safety Card (ICSC) on the World Wide Web (WWW)]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (1997) 0.75
[An international exchange and dissemination of chemical safety information on the Internet]. Eisei Shikenjo Hokoku (1996) 0.75
[Efficacy of influenza vaccination and its relationship to daily absentee rate]. Nihon Koshu Eisei Zasshi (1993) 0.75
[Clinical epidemiology of bronchial asthma in children report. No. II. Prognosis and house-environment]. Arerugi (1985) 0.75
An interpretation of normal ranges bases on individual difference quotient: extension to multivariate case. Med Inform (Lond) (1983) 0.75
Re: "Statistical modelling of lung cancer and laryngeal cancer incidence in Scotland, 1960-1979". Am J Epidemiol (1988) 0.75
[Dissemination of drug information on the Internet]. Eisei Shikenjo Hokoku (1996) 0.75
An interpretation of normal ranges based on a new concept "individual difference quotient" of clinical laboratory data. Med Inform (Lond) (1981) 0.75
[Prevalence of the HCV associated markers among blood donors in Japan]. Nihon Rinsho (1991) 0.75
[Normal distribution or log-normal distribution? (author's transl)]. Rinsho Byori (1979) 0.75
[A proposal for a new definition of excess mortality associated with influenza-epidemics and its estimation]. Nihon Koshu Eisei Zasshi (2001) 0.75
On the methods calculating mean survival time in 51Cr-platelet survival study. Am J Hematol (1980) 0.75
[Summaries on the first draft of the EHC monographs in 1990]. Eisei Shikenjo Hokoku (1991) 0.75
[Individual difference quotient of clinical laboratory data (author's transl)]. Rinsho Byori (1980) 0.75
[Studies of the factors affecting the reduction of chronic subdural hematoma: effect of preoperative factors with special reference to cerebral atrophy]. No Shinkei Geka (1988) 0.75
Confidence intervals for differences in correlated binary proportions. Stat Med (2000) 0.75
Intake ratio of water-insoluble dietary fiber to the water-soluble one in Japanese: an estimation on dietary records and the secular consideration on the national nutrition survey. J Nutr Sci Vitaminol (Tokyo) (1996) 0.75
[Preparation of the database and the Internet (WWW) homepage for regulations on chemicals in Japan]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (1999) 0.75
Disease clustering in time. Biometrics (1992) 0.75
[Preparation of data for based on various research--application of statistical methods]. Nihon Shokakibyo Gakkai Zasshi (1998) 0.75
[Development of a base system for information dissemination of the Internet]. Eisei Shikenjo Hokoku (1996) 0.75
A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus. J Hepatol (1998) 0.75
[Calcium metabolism in gout. I. A comparison with a population study]. Ryumachi (1975) 0.75
Immunoglobulin levels in patients on long-term hemodialysis. N Engl J Med (1981) 0.75
Anti-connectin monoclonal antibodies that react with the unc-22 gene product bind dense bodies of Caenorhabditis (Nematode) bodywall muscle cells. Tissue Cell (1989) 0.75
[On the proper interpretation of normal values by individual differences quotient (author's transl)]. Rinsho Byori (1981) 0.75
[Dissemination of drug information by the Internet]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (1998) 0.75
[A study of the trend of mortality from cirrhosis of the liver in Japan, 1955-79]. Nihon Eiseigaku Zasshi (1984) 0.75
Altered immune responsiveness in patients with chronic glomerulonephritis. Microbiol Immunol (1989) 0.75
[Population study of serum protein fraction. Part I.-Sex and age distribution of each component (author's transl)]. Rinsho Byori (1976) 0.75
[Changes in the nature of the red cell membrane in the process of hemolysis]. Nihon Ketsueki Gakkai Zasshi (1967) 0.75
Prediction of the development of cerebral palsy from perinatal risk factors. Brain Dev (1983) 0.75
[The status of NIHS Information and Computing Infrastructure (NICI)]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (2000) 0.75
[Basic x-ray picture of the large intestine using double contrast method]. Rinsho Hoshasen (1971) 0.75
On the asymptotic distribution of Tango's clustering index. Biometrics (1986) 0.75
[Development of domain specific search engines]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (2000) 0.75
[Studies on poisonings and incidents caused by chemicals in Japan]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (2000) 0.75
[Preparation of the database and the homepage on chemical accidents relating to health hazard]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (1998) 0.75
[Comparative study of new method and the Kawai and Fukutomi methods for estimating excess mortality associated with influenza-epidemics, based upon national vital statistics from 1975 to 1997]. Nihon Koshu Eisei Zasshi (2001) 0.75
[Development of NIHS Information and Computing Infrastructure (NICI)]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (1998) 0.75
[Clinical epidemiology of asthma in children. 1. Survey on allergic diseases at Oshima]. Arerugi (1983) 0.75
[Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia]. Rinsho Ketsueki (1999) 0.75
[The thymus gland and autoimmunity]. Saishin Igaku (1965) 0.75